Paper20058049
Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery.
Mitsuya K and 9 others. J Neurooncol, 2010. Cited by 150 papers, by iCite.
Cite this record
ConductScience Library. Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. Papers, record 20058049. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20058049
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| Magnetic Resonance Angiography | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Radiation Injuries | Major topic |
| Radiosurgery | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Cerebrovascular Circulation | |
| Contrast Media | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Prospective Studies | |
| Retrospective Studies | |
| Sensitivity and Specificity |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15087722 | Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results. | Invest Radiol | 2004 | https://conductscience.org/library/papers/15087722 | PubMed |
| 2 | 10318717 | Clinical applications of intracranial perfusion MR imaging. | Neuroimaging Clin N Am | 1999 | https://conductscience.org/library/papers/10318717 | PubMed |
| 3 | 15158627 | Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. | Lancet | 2004 | https://conductscience.org/library/papers/15158627 | PubMed |
| 4 | 8699239 | Association of rubidium and C-methionine uptake in brain tumors measured by positron emission tomography. | J Neurooncol | 1996 | https://conductscience.org/library/papers/8699239 | PubMed |
| 5 | 16937146 | Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging. | Neuroradiology | 2006 | https://conductscience.org/library/papers/16937146 | PubMed |
| 6 | 7526239 | Effect of radiosurgery using Leksell gamma unit on metastatic brain tumor--autopsy case report. | Neurol Med Chir (Tokyo) | 1994 | https://conductscience.org/library/papers/7526239 | PubMed |
| 7 | 11079496 | PET in differentiation of recurrent brain tumor from radiation injury. | J Nucl Med | 2000 | https://conductscience.org/library/papers/11079496 | PubMed |
| 8 | 17986939 | First-pass perfusion computed tomography: initial experience in differentiating recurrent brain tumors from radiation effects and radiation necrosis. | Neurosurgery | 2007 | https://conductscience.org/library/papers/17986939 | PubMed |
| 9 | 15502131 | Characterization of a first-pass gradient-echo spin-echo method to predict brain tumor grade and angiogenesis. | AJNR Am J Neuroradiol | 2004 | https://conductscience.org/library/papers/15502131 | PubMed |
| 10 | 2345506 | Perfusion imaging with NMR contrast agents. | Magn Reson Med | 1990 | https://conductscience.org/library/papers/2345506 | PubMed |
| 11 | 11856703 | Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. | AJR Am J Roentgenol | 2002 | https://conductscience.org/library/papers/11856703 | PubMed |
| 12 | 17886561 | Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imaging. | J Neurosurg | 2007 | https://conductscience.org/library/papers/17886561 | PubMed |
| 13 | 14585263 | The management of brain metastases. | Cancer Treat Rev | 2003 | https://conductscience.org/library/papers/14585263 | PubMed |
| 14 | 16172969 | Differentiation of the radiation-induced necrosis and tumor recurrence after gamma knife radiosurgery for brain metastases: importance of multi-voxel proton MRS. | Minim Invasive Neurosurg | 2005 | https://conductscience.org/library/papers/16172969 | PubMed |
| 15 | 16611778 | Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? | AJNR Am J Neuroradiol | 2006 | https://conductscience.org/library/papers/16611778 | PubMed |
| 16 | 8134596 | Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. | Radiology | 1994 | https://conductscience.org/library/papers/8134596 | PubMed |
| 17 | 18413375 | Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. | J Nucl Med | 2008 | https://conductscience.org/library/papers/18413375 | PubMed |
| 18 | 10815666 | Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. | AJNR Am J Neuroradiol | 2000 | https://conductscience.org/library/papers/10815666 | PubMed |
| 19 | 12744366 | Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? | J Neurosurg | 2003 | https://conductscience.org/library/papers/12744366 | PubMed |
| 20 | 12461273 | In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. | Radiology | 2002 | https://conductscience.org/library/papers/12461273 | PubMed |
Cited by101
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 150 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42938876 | Qualitative Dynamic Contrast-Enhanced MRI Time-Intensity Curve Analysis for Differentiating Non-Progressive Treatment-Related Changes from Tumor Progression After Stereotactic Radiotherapy for Brain Metastases. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42938876 | PubMed |
| 42926244 | MRI of brain metastases in the era of immunotherapy, targeted agents, and artificial intelligence: from detection to treatment response assessment. | MAGMA | 2026 | https://conductscience.org/library/papers/42926244 | PubMed |
| 42774457 | Diagnostic imaging and emerging image-guided neurointervention in brain tumors: a narrative review. | Front Radiol | 2026 | https://conductscience.org/library/papers/42774457 | PubMed |
| 42663779 | Pathology-validated structural and physiologic habitat imaging for differentiating radiation necrosis from tumor recurrence in brain metastases. | J Neurooncol | 2026 | https://conductscience.org/library/papers/42663779 | PubMed |
| 42571295 | A clinical decision-support framework to differentiate radiation necrosis from tumor progression in brain metastases. | Neurooncol Adv | 2026 | https://conductscience.org/library/papers/42571295 | PubMed |
| 42543812 | Descriptive Analysis of Surgically Resected Pure Radiation Necrosis After Radiation Therapy for Brain Metastasis: Clinical Features, MRI Findings, and Outcomes. | Brain Tumor Res Treat | 2026 | https://conductscience.org/library/papers/42543812 | PubMed |
| 42484747 | The threefold value of surgery in previously irradiated brain metastases. | J Neurooncol | 2026 | https://conductscience.org/library/papers/42484747 | PubMed |
| 42166098 | Percentage signal recovery plus relative cerebral blood volume: a practical dual-parameter strategy for differentiating post-stereotactic radiosurgery tumour progression from radiation necrosis in brain metastases. | Insights Imaging | 2026 | https://conductscience.org/library/papers/42166098 | PubMed |
| 42073362 | A Challenging Differential Diagnosis Between Brain Radionecrosis and Recurrent Metastatic Disease, with Temporary Clinical/Radiological Response to Bevacizumab and Later Imaging Suspicious for Oligoprogression. | Life (Basel) | 2026 | https://conductscience.org/library/papers/42073362 | PubMed |
| 41451222 | MRI features and preliminary diagnostic assessment using large language models of cystic tumor progression mimicking radiation necrosis in brain metastasis patients treated with immunotherapy: case report. | Front Immunol | 2025 | https://conductscience.org/library/papers/41451222 | PubMed |
| 41160301 | Percentage of signal recovery (PSR): a more accurate marker than rCBV for differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiosurgery. | J Neurooncol | 2025 | https://conductscience.org/library/papers/41160301 | PubMed |
| 41036533 | Cerebral radiation necrosis successfully treated with high-dose bevacizumab. | Respir Med Case Rep | 2025 | https://conductscience.org/library/papers/41036533 | PubMed |
| 41030686 | Predicting Radionecrosis After Stereotactic Radiation Therapy for Solitary Brain Metastases: External Validation of a Univariable Model and Development of a Multivariable Model. | Adv Radiat Oncol | 2025 | https://conductscience.org/library/papers/41030686 | PubMed |
| 40913628 | FLAIR extending beyond a quadrant (FEQ) of the cerebrum as a qualitative imaging biomarker: a conceptual proposition and proof-of-principle. | Clin Exp Metastasis | 2025 | https://conductscience.org/library/papers/40913628 | PubMed |
| 40805286 | Auxiliary Value of [18F]F-Fluorocholine PET/CT in Evaluating Post-Stereotactic Radiosurgery Recurrence of Lung Cancer Brain Metastases: A Comparative Analysis with Contrast-Enhanced MRI. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40805286 | PubMed |
| 40408063 | Predictive value of early DCE and DSC perfusion MRI parameters for midterm clinical outcomes in lung cancer brain metastases treated with stereotactic radiosurgery. | J Neurooncol | 2025 | https://conductscience.org/library/papers/40408063 | PubMed |
| 40360909 | Development of a recursive partitioning analysis for prediction of radiation necrosis following single-fraction stereotactic radiosurgery for intact brain metastases. | J Neurooncol | 2025 | https://conductscience.org/library/papers/40360909 | PubMed |
| 40217619 | A Practical, Short, [18F]F-DOPA PET/CT Acquisition Method for Distinguishing Recurrent Brain Metastases from Radionecrosis Following Radiotherapy. | J Clin Med | 2025 | https://conductscience.org/library/papers/40217619 | PubMed |
| 40172476 | AI differentiates radionecrosis from true progression in brain metastasis upon stereotactic radiosurgery: Analysis of 124 histologically assessed lesions. | Neuro Oncol | 2025 | https://conductscience.org/library/papers/40172476 | PubMed |
| 40057844 | Differentiation Between Radiation Necrosis and True Tumour Progression After Radiotherapy to Intracranial Metastases. | J Med Imaging Radiat Oncol | 2025 | https://conductscience.org/library/papers/40057844 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20058049
GET https://conductscience.org/api/papers/v1/20058049/references?page=2